Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

BUY
$36.95 - $82.41 $342,230 - $763,281
9,262 New
9,262 $419,000
Q4 2021

Feb 08, 2022

SELL
$135.05 - $182.59 $234,987 - $317,706
-1,740 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$134.22 - $202.37 $233,542 - $352,123
1,740 New
1,740 $341,000
Q1 2021

May 12, 2021

SELL
$140.25 - $196.86 $268,438 - $376,790
-1,914 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $242,063 - $313,321
1,914 New
1,914 $271,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.